SCHEMBL236628

SCHEMBL236628

CCOC(=O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MME P08473 8/20 0.55
ACE P12821 7/20 0.55
CPA1 P15085 7/20 0.55
ACE2 Q9BYF1 7/20 0.55
L3MBTL1 Q9Y468 1/20 0.49
MMP2 P08253 1/20 0.48
MMP7 P09237 1/20 0.48
MMP9 P14780 1/20 0.48
MMP12 P39900 1/20 0.48
MMP13 P45452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10752313 0.93 ALDH1A1 (0.50) MMEACECPA1ACE2
SCHEMBL10752317 0.93 ALDH1A1 (0.50) MMEACECPA1ACE2
SCHEMBL30375020 0.89 SLC15A1 (0.58) MMEACECPA1ACE2
SCHEMBL12202988 0.88 MME (0.56) MMEACECPA1ACE2MMP2
SCHEMBL135150 0.88 MME (0.56) MMEACECPA1ACE2MMP2
SCHEMBL11122650 0.88 MME (0.56) MMEACECPA1ACE2MMP2
SCHEMBL7257544 0.88 MME (0.50) MMEACECPA1ACE2L3MBTL1
Hydrochloric Acid SCHEMBL10765384 0.87 MME (0.55) MMEACECPA1ACE2MMP2
SCHEMBL7101568 0.84 MMP8 (0.51) MMP2
SCHEMBL13963726 0.83 MME (0.64) MMEACECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389240-B2 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester AJINOMOTO CO., INC. (JP) 2013-03-05 US disclosed
US-8361748-B2 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester AJINOMOTO CO., INC. (JP) 2013-01-29 US disclosed
US-20120301918-A1 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER AJINOMOTO CO., INC. (JP) 2012-11-29 US disclosed
US-20120295304-A1 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER AJINOMOTO CO., INC. (JP) 2012-11-22 US disclosed
EP-2180060-B1 Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester AJINOMOTO KK (JP) 2012-08-29 EP disclosed
EP-2180061-B1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester AJINOMOTO KK (JP) 2012-08-29 EP disclosed
US-8247193-B2 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester AJINOMOTO CO., INC. (JP) 2012-08-21 US disclosed
EP-2180059-B1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester AJINOMOTO KK (JP) 2012-06-27 EP disclosed
EP-2157188-B1 Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester AJINOMOTO KK (JP) 2012-05-02 EP disclosed
EP-2166109-B1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester AJINOMOTO KK (JP) 2012-02-22 EP disclosed
EP-2180061-A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester Ajinomoto Co., Inc. (JP) 2010-04-28 EP disclosed
EP-2166109-A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester Ajinomoto Co., Inc. (JP) 2010-03-24 EP disclosed
EP-2157188-A1 Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester Ajinomoto Co., Inc. (JP) 2010-02-24 EP disclosed
EP-1587941-B1 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER AJINOMOTO KK (JP) 2009-08-05 EP disclosed
US-20090191600-A1 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER AJINOMOTO CO., INC. (JP) 2009-07-30 US disclosed
US-7361458-B2 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester AJINOMOTO CO., INC. (JP) 2008-04-22 US disclosed
EP-1587941-A4 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER AJINOMOTO KK (JP) 2006-06-21 EP disclosed
EP-1587941-A1 METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER Ajinomoto Co., Inc. (JP) 2005-10-26 EP disclosed
US-20050124035-A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther AJINOMOTO CO., INC. (JP) 2005-06-09 US disclosed
WO-2004065610-A1 METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER AJINOMOTO CO., INC. (JP) 2004-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124035-A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther DNPEP, ASPH, PEPD MME 49/4885ACE 74/4885CPA1 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.